An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Editorial by Theressa Henne and Clara Saillant (UNIVIE) The Value of Health Data - Results from the CPDP Moot Court “Honoured judge, We stand in front of your Court today to seek justice and clarity on a matter that is of great concern to our society. My company has...
by Luis Bonmati, Scientific Coordinator of EUCAIM project Presentation of the European Federation for Cancer Images Introducing EUCAIM: A Pan-European Initiative The goal of EUropean Federation for CAncer IMages (EUCAIM) is to build a pan-European digital federated...
Interview with Dr. Kai Vilanova, Director MRI Clínica Girona, Coordinator Radiology, Faculty of Medicine, University of Girona. Director School of MRI-ESMRMB (IDIBGI) How can the results of the ProCAncer-I project help radiologists? What are the problems that...
By Prof Kostas Marias Hellenic Mediterranean University, Head Computational BioΜedicine Lab - FORTH Enabling AI Models Traceability through ProCAncer-I AI Model Passport Artificial intelligence (AI) has brought great economic and social prospects to human society with...
By Ana Castro Verde, Ph.D. student and research technician at Computational Clinical Imaging Group, Champalimaud Foundation Clinical Challenge: Can radical prostatectomy patients help promote a biological validation of radiomics signatures? Prostate cancer patients...
National Cancer Institute is the only specialized oncology institution in Lithuania. The Institute acts as the clinical cancer center, certified and accredited by the Organization of European Cancer Institutes. • In order to achieve our strategic objectives, we...
Established in 2016, Advantis Medical Imaging makes advanced medical imaging more accessible, user-friendly and data-driven by merging it with cloud technology. By providing AI-driven, reliable and automated MRI software solutions, Advantis is on a mission to...
Newsletter #5 Contents
Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...
We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025. Date: 26 February 2025 Time: 15:00 – 16:00 Location: ECR 2025, Vienna, Austria (conference...
ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces